Core Viewpoint - The nuclear power sector experienced a decline on Thursday, with notable drops in stock prices for several companies in the industry [1] Company Summaries - Duke Energy (DUK.US) saw a decrease of 0.69% in its stock price [1] - BWX Technologies (BWXT.US) reported a decline of 0.87% [1] - Oklo Inc (OKLO.US) experienced a significant drop of over 6.9% [1] - NuScale Power (SMR.US) fell by more than 5.3% [1]

Group 1 - The Value Lab focuses on long-only value investment strategies, aiming to identify mispriced international equities with a target portfolio yield of approximately 4% [1][2] - The SPDR® Bloomberg International Treasury Bond ETF (BWX) is highlighted as a higher-duration international government bond portfolio, with a significant allocation towards Japanese bonds, which are known for high debt rates [2] - The Valkyrie Trading Society consists of analysts who share high-conviction investment ideas in developed markets, emphasizing downside protection and the potential for non-correlated, outsized returns in the current economic climate [3]

Company Overview - BWX Technologies, Inc. (BWXT) has experienced a significant gap up in stock price due to strong earnings and a potential plan by President Trump to build a nuclear reactor on the moon by 2030 [10] - BWXT is one of the 12 nuclear stocks on the list and supplies nuclear reactors to the U.S. Navy [10] Market Sentiment - There is extreme positive sentiment in the stock market, particularly towards nuclear stocks, driven by the potential moon reactor plan [10] - Other nuclear stocks such as Oklo Inc (OKLO), Nuscale Power Corp (SMR), Centrus Energy Corp (LEU), and Nano Nuclear Energy Inc (NNE) have also seen aggressive buying [10] Earnings Reports - Advanced Micro Devices Inc (AMD) reported strong earnings but fell short of whisper numbers, leading to a 6% decline in premarket trading [10] - McDonald's Corp (MCD) and Shopify Inc (SHOP) reported earnings better than consensus and whisper numbers, while Walt Disney Co (DIS), Uber Technologies Inc (UBER), and Amgen Inc (AMGN) reported earnings below whisper numbers [10] Economic Indicators - The ISM Services data came in at 50.1%, below the consensus of 51.5%, indicating potential economic contraction [10] - The prices subindex was reported at 69.9, and the employment subindex at 46.4, contributing to concerns about stagflation [10] Investment Strategies - Investors are advised to consider protection bands consisting of cash or Treasury bills, as well as short to medium-term hedges [11] - A traditional 60/40 portfolio may need to focus on high-quality bonds and bonds of five years duration or less, given the current market conditions [15]

Core Viewpoint - The nuclear power sector experienced a significant increase in stock prices, driven by positive earnings guidance from BWX Technologies for the fiscal year 2025 [1] Company Summaries - BWX Technologies (BWXT.US) saw its stock rise over 16% after raising its earnings guidance for the fiscal year 2025 [1] - Oklo Inc (OKLO.US) experienced a stock increase of over 8.5% [1] - NuScale Power (SMR.US) had a stock price increase of over 3.6% [1] - Duke Energy (DUK.US) saw its stock rise by over 2% [1]

Core Insights - BWX Technologies reported strong Q2 2025 results, with revenue of $764.0 million, exceeding analyst estimates of $711.1 million, and non-GAAP EPS of $1.02, surpassing the consensus of $0.79 [1][2] - The company's backlog reached a record $6.0 billion, prompting an increase in revenue and earnings forecasts for 2025 [1][8] - Despite strong overall growth, challenges in commercial profit margins were noted, particularly due to raw material cost pressures [1][5] Financial Performance - Non-GAAP EPS for Q2 2025 was $1.02, a 24% increase from $0.82 in Q2 2024 [2] - GAAP revenue was $764.0 million, reflecting a 12% year-over-year growth from $681.5 million [2] - Adjusted EBITDA rose 16% to $145.9 million compared to $126.2 million in Q2 2024 [2][7] - Free cash flow significantly improved to $126.3 million from $35.5 million in Q2 2024, marking a 256.1% increase [2][7] Business Segments - BWX Technologies operates in two main segments: Government Operations and Commercial Operations [3] - Government Operations generated $589.0 million in GAAP revenue, up 9% year-over-year, with a record backlog of $4.44 billion [5] - Commercial Operations reported revenue of $176.1 million, a 24% increase from Q2 2024, but faced a 59% drop in operating income due to unfavorable project mix and increased costs [5] Strategic Developments - The acquisition of Kinectrics in May 2025 aims to enhance BWXT's capabilities in nuclear lifecycle services and radiopharmaceuticals [6] - The consolidated order backlog reached a record $6.0 billion, supported by recent acquisitions [6] - The company is expanding manufacturing capabilities, including scaling up operations at its Cambridge facility in Canada [6] Financial Outlook - Management raised its 2025 financial guidance, projecting revenue near $3.1 billion and non-GAAP EPS of $3.65–$3.75 [8] - Adjusted EBITDA is now expected to be between $565 million and $575 million, with free cash flow guidance increased to $275–$285 million [8] - Key factors to monitor include margin recovery in Commercial Operations and the integration of newly acquired businesses [8]

Company Performance - BWX Technologies (BWXT) reported quarterly earnings of $1.02 per share, exceeding the Zacks Consensus Estimate of $0.79 per share, and up from $0.82 per share a year ago, adjusted for non-recurring items [1] - The earnings surprise for this quarter was +29.11%, following a previous quarter where earnings were $0.91 per share against an expectation of $0.73, resulting in a surprise of +24.66% [2] - The company achieved revenues of $764.04 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 6.73%, and an increase from $681.47 million year-over-year [3] Stock Performance - BWX shares have increased approximately 34.2% since the beginning of the year, significantly outperforming the S&P 500's gain of 6.1% [4] - The current consensus EPS estimate for the upcoming quarter is $0.87 on revenues of $786.52 million, and for the current fiscal year, it is $3.55 on revenues of $3.05 billion [8] Industry Outlook - The Aerospace - Defense Equipment industry, to which BWX belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, indicating potential challenges ahead [9] - The performance of BWX may be influenced by the overall outlook of the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [9]

Financial Data and Key Metrics Changes - The second quarter revenue was $764 million, up 12% year-over-year, with organic revenue growth of 4% excluding acquisitions [19][20] - Adjusted EBITDA increased to $146 million, a 16% year-over-year growth, driven by strong performance in government operations [20][22] - Adjusted earnings per share rose to $1.02, reflecting a 24% increase, supported by lower tax rates and foreign currency gains [20][26] - Free cash flow for the quarter was robust at $126 million, aided by effective working capital management [21][26] Business Line Data and Key Metrics Changes - Government operations revenue grew by 9%, with adjusted EBITDA up 23% to $133 million, yielding an adjusted EBITDA margin of 22.6% [22][23] - Commercial operations reported revenue growth of 24%, but organic revenue was down 3%, primarily due to a decline in commercial power [23][24] - The backlog increased to $6 billion, a 23% quarter-over-quarter and 70% year-over-year growth, with organic book-to-bill at 2.2 [7][19] Market Data and Key Metrics Changes - Demand across global security, clean energy, and medical end markets is accelerating, with significant growth opportunities identified [6][28] - The naval propulsion business is expected to maintain a revenue CAGR of 3% to 5% over the long term, supported by recent pricing agreements [9][10] - The commercial power segment is experiencing strong demand, particularly in the Candu market, with ongoing life extensions and potential new builds [17][18] Company Strategy and Development Direction - The company is focused on enhancing capabilities in the nuclear market through both organic and inorganic investments, including the recent acquisition of Kinetrix [6][28] - Strategic priorities include operational excellence and expanding service offerings in nuclear power and energy infrastructure markets [6][10] - The company anticipates significant growth in advanced nuclear fuel opportunities and is well-positioned to capture emerging market demands [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong operational performance and backlog, indicating a positive outlook for the remainder of the year [28][26] - The company is raising its guidance for revenue, adjusted EBITDA, and earnings per share, reflecting better-than-expected operational performance [26][27] - Management noted that while the second half may see some normalization in performance, the overall operational conditions remain strong [102][103] Other Important Information - The company is actively pursuing advanced nuclear fuel opportunities and has received government support for various projects [11][90] - The recent reconciliation bill is expected to provide additional funding for nuclear programs, enhancing the company's growth prospects [90][91] Q&A Session Summary Question: Clarification on $29 million favorable contract adjustment - The $29 million relates to a special materials contract, with part included in the original guidance but more favorable than anticipated [31][32] Question: Opportunities for securing content on new build AP1000s - The company has an MOU with Westinghouse to potentially manufacture components for AP1000 reactors, with significant opportunities expected [33][34] Question: Impact of Kevin McCoy's appointment as Chief Nuclear Officer - Kevin McCoy is seconded to the Department of Defense, and his role is to assist with nuclear shipbuilding, while Joe Miller has been promoted to President of Government Operations [41][42] Question: Drivers of improved government operations margins - Margins were positively impacted by strong operating performance and favorable contract performance, with expectations for continued strong performance [42][43] Question: Revenue recognition for the first reactor in Darlington - Revenue for the X300 reactor is expected to be evenly distributed over a four-year period, with significant opportunities for additional reactors [92][93] Question: Growth in backlog and organic vs acquisition contributions - The majority of the backlog growth was organic, with approximately $240 million attributed to acquisitions [108] Question: Impact of critical minerals shortages - The company is not experiencing significant pressure from critical minerals, managing commodity risks effectively [109][110]

Financial Data and Key Metrics Changes - The second quarter revenue was $764 million, up 12% year-over-year, with organic revenue growth of 4% excluding acquisitions [18][19] - Adjusted EBITDA increased to $146 million, a 16% year-over-year growth, driven by strong performance in government operations [19][21] - Adjusted earnings per share rose to $1.02, reflecting a 24% increase, supported by lower tax rates and foreign currency gains [19][20] - Free cash flow for the quarter was robust at $126 million, aided by effective working capital management [20] Business Line Data and Key Metrics Changes - Government operations revenue grew by 9%, with adjusted EBITDA up 23% to $133 million, yielding an adjusted EBITDA margin of 22.6% [21] - Commercial operations reported revenue growth of 24%, but organic revenue was down 3%, primarily due to a decline in commercial power [22][23] - The backlog increased to $6 billion, a 23% quarter-over-quarter and 70% year-over-year growth, with organic book-to-bill at 2.2 [5][6] Market Data and Key Metrics Changes - Demand across global security, clean energy, and medical end markets is accelerating, with significant growth opportunities identified [5] - The naval propulsion business is expected to maintain a revenue CAGR of 3% to 5% over the long term, supported by recent contracts [7] - The medical segment is projected to achieve over 20% growth this year, driven by strong demand for diagnostic and therapeutic isotopes [13] Company Strategy and Development Direction - The company is focused on enhancing capabilities in the nuclear market through both organic and inorganic investments, including the recent acquisition of Kinetrix [27] - The strategy includes expanding life of plant services capabilities and responding to increasing demand in various end markets [5][27] - The company aims to leverage its operational excellence to drive shareholder value and capitalize on emerging opportunities in advanced nuclear technologies [27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational performance and backlog, indicating a strong start to the year both financially and strategically [27] - The company anticipates continued strong performance in government operations and is raising guidance for revenue, adjusted EBITDA, and earnings per share for the year [25][26] - Management noted that while the second half may normalize from a strong first half, operational conditions remain favorable [110] Other Important Information - The company is actively pursuing advanced nuclear fuel opportunities and has a unique position in producing TriSil fuel at scale [70][92] - The recent reconciliation bill is expected to provide additional funding for nuclear programs, enhancing the company's growth prospects [96] Q&A Session Summary Question: Clarification on favorable contract adjustment - Management confirmed that a $29 million favorable contract adjustment relates to special materials contracts, with part included in original guidance [30][31] Question: Opportunities for securing content on new build AP1000s - Management indicated an MOU with Westinghouse to potentially manufacture components for AP1000 reactors, with opportunities for high-pressure components [32] Question: Impact of Kevin McCoy's appointment as Chief Nuclear Officer - Management clarified that McCoy is seconded to the Department of Defense, and Joe Miller has been promoted to President of Government Operations [40][41] Question: Drivers of improved government operations margins - Management attributed margin improvements to favorable contract performance and operational efficiencies, expecting continued strong performance [42][43] Question: Contribution of Kinetrix acquisition to guidance increase - Management noted that while Kinetrix contributed to guidance, the majority of the increase was due to timing and performance in government operations [58] Question: Engagement level in nuclear projects - Management reported high activity across all end markets, with strong government appetite and compounding growth in the medical sector [90][91] Question: Impact of critical minerals shortages - Management stated that they are not experiencing significant pressure from critical minerals, managing commodity risk effectively [117][119]

Second-Quarter 2025 Earnings Call Presentation Reported August 4, 2025 © 2025 BWX Technologies. Inc. All Rights Reserved. The products and services described herein are provided by subsidiaries of BWX Technologies, Inc. Forward-Looking Statements Disclaimer Our Purpose: We employ nuclear technology to solve some of the world's most important problems Our Mission: We provide safe and effective nuclear solutions for global security, clean energy, environmental remediation, nuclear medicine, and space explorat ...

[PART I – FINANCIAL INFORMATION](index=3&type=section&id=PART%20I%20%E2%80%93%20FINANCIAL%20INFORMATION) This section presents BWX Technologies' unaudited condensed consolidated financial statements for Q2 and H1 2025, detailing financial performance, asset growth from acquisitions, and significant investing cash outflows [Item 1. Condensed Consolidated Financial Statements](index=3&type=section&id=Item%201.%20Condensed%20Consolidated%20Financial%20Statements) This section presents BWX Technologies' unaudited condensed consolidated financial statements for Q2 and H1 2025, including income, balance sheet, and cash flow statements, along with accompanying notes [Condensed Consolidated Statements of Income](index=3&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income) This section details the company's revenues, operating income, and net income for the three and six months ended June 30, 2025 and 2024, showing year-over-year growth Consolidated Income Statement Highlights (Unaudited, In thousands, except per share amounts) | Metric | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | :--- | :--- | | **Revenues (in thousands)** | $764,039 | $681,465 | $1,446,297 | $1,285,431 | | **Operating Income (in thousands)** | $102,424 | $98,806 | $199,054 | $191,767 | | **Net Income Attributable to BWXT (in thousands)** | $78,388 | $72,972 | $153,850 | $141,440 | | **Diluted EPS** | $0.85 | $0.79 | $1.68 | $1.54 | - Revenues for the second quarter of 2025 increased by **12.1%** year-over-year to **$764.0 million**, while net income grew by **7.4%** to **$78.4 million**[9](index=9&type=chunk) - For the first six months of 2025, revenues increased by **12.5%** year-over-year to **$1.45 billion**, and net income grew by **8.8%** to **$153.9 million**[9](index=9&type=chunk) [Condensed Consolidated Balance Sheets](index=5&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) This section presents the company's financial position, including assets, liabilities, and equity, as of June 30, 2025, and December 31, 2024, highlighting asset growth from acquisitions Consolidated Balance Sheet Highlights (Unaudited, In thousands) | Metric | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Total Current Assets (in thousands)** | $996,885 | $929,997 | | **Property, Plant and Equipment, Net (in thousands)** | $1,537,771 | $1,278,161 | | **Goodwill (in thousands)** | $512,602 | $287,362 | | **TOTAL ASSETS (in thousands)** | **$3,699,072** | **$2,869,924** | | **Total Current Liabilities (in thousands)** | $590,186 | $474,201 | | **Long-Term Debt (in thousands)** | $1,519,728 | $1,042,970 | | **Total Stockholders' Equity (in thousands)** | $1,183,906 | $1,080,404 | | **TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (in thousands)** | **$3,699,072** | **$2,869,924** | - Total assets increased significantly to **$3.70 billion** at June 30, 2025, from **$2.87 billion** at December 31, 2024, primarily due to increases in Goodwill, Intangible Assets, and Property, Plant and Equipment resulting from recent acquisitions[14](index=14&type=chunk) - Long-term debt increased to **$1.52 billion** from **$1.04 billion**, reflecting borrowings to finance acquisitions[16](index=16&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) This section outlines the company's cash inflows and outflows from operating, investing, and financing activities for the first six months of 2025 and 2024, emphasizing acquisition-driven cash usage Consolidated Cash Flow Highlights (Unaudited, In thousands) | Metric | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | **Net Cash Provided by Operating Activities (in thousands)** | $209,693 | $98,920 | | **Net Cash Used in Investing Activities (in thousands)** | ($629,480) | ($60,624) | | **Net Cash Provided by (Used in) Financing Activities (in thousands)** | $385,826 | ($65,004) | | **Total Decrease in Cash (in thousands)** | ($36,436) | ($27,016) | | **Cash at End of Period (in thousands)** | $44,135 | $54,599 | - Cash from operations more than doubled to **$209.7 million** for the first six months of 2025 compared to the same period in 2024, driven by favorable changes in working capital[20](index=20&type=chunk) - Investing activities used **$629.5 million**, a significant increase from **$60.6 million** in the prior year, primarily due to **$538.2 million** spent on acquisitions[20](index=20&type=chunk) - Financing activities provided **$385.8 million**, mainly from net borrowings of long-term debt to fund acquisitions, a reversal from the **$65.0 million** used in the prior year period[20](index=20&type=chunk) [Notes to Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) These notes detail accounting policies, provide disaggregated revenue and segment performance data, and offer further information on debt and significant 2025 acquisitions - On January 3, 2025, the company acquired Aerojet Ordnance Tennessee, Inc. (A.O.T.) for approximately **$103.3 million**, enhancing its capabilities in advanced materials for the Government Operations segment[46](index=46&type=chunk) - On May 20, 2025, the company acquired Kinectrics Inc. for **CAD $782.7 million** (**$441.4 million** U.S. dollar equivalent, net of assumed liabilities), expanding its lifecycle management services and isotope production for the Commercial Operations segment[48](index=48&type=chunk)[49](index=49&type=chunk) - Remaining performance obligations (backlog) stood at **$6.015 billion** as of June 30, 2025, with approximately **53%** expected to be recognized as revenue by the end of 2026[58](index=58&type=chunk) Segment Revenues and Operating Income (Six Months Ended June 30) | Metric | 2025 (in thousands) | 2024 (in thousands) | | :--- | :--- | :--- | | **Government Operations Revenue** | $1,144,246 | $1,027,967 | | **Government Operations Operating Income** | $207,163 | $178,206 | | **Commercial Operations Revenue** | $304,449 | $258,529 | | **Commercial Operations Operating Income** | $13,342 | $25,219 | [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=22&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses financial performance, highlighting revenue and operating income growth driven by Government Operations, the impact of recent acquisitions, increased backlog, and sufficient liquidity [Results of Operations](index=25&type=section&id=Results%20of%20Operations) Consolidated revenues and operating income grew in Q2 and H1 2025, primarily driven by Government Operations, while Commercial Operations' income declined despite revenue growth due to product mix and M&A costs Segment Performance Summary (Q2 2025 vs Q2 2024) | Segment | Q2 2025 Revenue (in thousands) | Q2 2024 Revenue (in thousands) | Q2 2025 Operating Income (in thousands) | Q2 2024 Operating Income (in thousands) | | :--- | :--- | :--- | :--- | :--- | | **Government Operations** | $588,959 | $540,846 | $109,417 | $92,520 | | **Commercial Operations** | $176,139 | $141,491 | $6,877 | $16,628 | - Government Operations revenue in Q2 2025 increased by **8.9%** YoY, driven by uranium processing and downblending operations, including contributions from the A.O.T. acquisition[103](index=103&type=chunk) - Commercial Operations revenue in Q2 2025 increased by **24.5%** YoY, primarily due to the Kinectrics acquisition, but operating income fell from **$16.6 million** to **$6.9 million** due to unfavorable product mix and M&A expenses[108](index=108&type=chunk)[109](index=109&type=chunk) [Backlog](index=28&type=section&id=Backlog) Total company backlog increased to **$6.0 billion** at June 30, 2025, with growth in both Government and Commercial Operations, and 53% expected to be recognized by end of 2026 Backlog by Segment (in approximate millions) | Segment | June 30, 2025 (in millions) | December 31, 2024 (in millions) | | :--- | :--- | :--- | | **Government Operations** | $4,436 | $3,913 | | **Commercial Operations** | $1,580 | $930 | | **Total Backlog** | **$6,016** | **$4,843** | - The backlog at June 30, 2025, includes **$651.4 million** of unfunded backlog related to U.S. Government contracts[121](index=121&type=chunk) - Approximately **$1.4 billion** in unexercised options, expected to be awarded in 2026 subject to Congressional appropriations, are excluded from the backlog[123](index=123&type=chunk) [Liquidity and Capital Resources](index=28&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains adequate liquidity through its Credit Facility and Senior Notes, with increased cash from operations and significant cash used in investing activities due to acquisitions - As of June 30, 2025, total debt included **$231.3 million** under the Term Loan, **$505.0 million** in borrowings under the Revolving Credit Facility, and **$800 million** in Senior Notes[131](index=131&type=chunk)[134](index=134&type=chunk)[138](index=138&type=chunk) - Net cash from operating activities increased to **$209.7 million** in H1 2025 from **$98.9 million** in H1 2024, primarily due to the timing of project cash flows[146](index=146&type=chunk) - Net cash used in investing activities increased to **$629.5 million** in H1 2025, driven by the acquisitions of A.O.T. (**$103.3 million**) and Kinectrics (**$434.4 million**)[147](index=147&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=33&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company reports no material changes to its market risk exposures since the 2024 Annual Report on Form 10-K - There have been no material changes to the company's market risk exposures since the 2024 10-K report[152](index=152&type=chunk) [Item 4. Controls and Procedures](index=34&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded disclosure controls were effective as of June 30, 2025, with Kinectrics integration into internal controls ongoing into 2026 - The CEO and CFO concluded that the company's disclosure controls and procedures are effective as of June 30, 2025[153](index=153&type=chunk) - The company is in the process of integrating Kinectrics, acquired during the quarter, into its internal control over financial reporting. This integration is expected to continue into 2026[154](index=154&type=chunk) [PART II – OTHER INFORMATION](index=35&type=section&id=PART%20II%20%E2%80%93%20OTHER%20INFORMATION) This section provides other information not covered in the financial statements, including legal proceedings, risk factors, equity sales, and exhibits [Item 1. Legal Proceedings](index=35&type=section&id=Item%201.%20Legal%20Proceedings) The company reports no material legal proceedings for the period, referencing Note 5 for contingencies - The company reports no material legal proceedings for the period, referencing Note 5 which states there were no material contingencies[61](index=61&type=chunk)[157](index=157&type=chunk) [Item 1A. Risk Factors](index=35&type=section&id=Item%201A.%20Risk%20Factors) The company reports no material changes to its risk factors since the 2024 Annual Report on Form 10-K - There have been no material changes to the risk factors previously disclosed in the 2024 10-K[158](index=158&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=35&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company repurchased 92 shares for tax withholding in Q2 2025, with **$347.6 million** remaining under the authorized share repurchase program Share Repurchases (Q2 2025) | Period | Total Shares Purchased | Average Price Paid | Shares Purchased as Part of Public Program | Approx. Dollar Value Remaining for Purchase (in millions) | | :--- | :--- | :--- | :--- | :--- | | April 2025 | 37 | $103.55 | — | $347.6 | | May 2025 | 55 | $110.82 | — | $347.6 | | June 2025 | — | $— | — | $347.6 | | **Total** | **92** | **$107.90** | **—** | **$347.6** | - The Board of Directors authorized a **$500 million** share repurchase program on April 30, 2021, with no expiration date[161](index=161&type=chunk) [Item 5. Other Information](index=35&type=section&id=Item%205.%20Other%20Information) No directors or officers adopted or terminated Rule 10b5-1 trading arrangements during Q2 2025 - No directors or officers of the company adopted or terminated any Rule 10b5-1 trading arrangements during the three months ended June 30, 2025[162](index=162&type=chunk) [Item 6. Exhibits](index=36&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including corporate governance documents, credit agreement amendments, and CEO/CFO certifications - Exhibits filed include certifications by the CEO and CFO (Exhibits 31.1, 31.2, 32.1, 32.2) and an amendment to the credit agreement (Exhibit 10.2)[164](index=164&type=chunk)